Literature DB >> 10364308

ICP22 and the UL13 protein kinase are both required for herpes simplex virus-induced modification of the large subunit of RNA polymerase II.

M C Long1, V Leong, P A Schaffer, C A Spencer, S A Rice.   

Abstract

Herpes simplex virus type 1 (HSV-1) infection alters the phosphorylation of the large subunit of RNA polymerase II (RNAP II), resulting in the depletion of the hypophosphorylated and hyperphosphorylated forms of this polypeptide (known as IIa and IIo, respectively) and induction of a novel, alternatively phosphorylated form (designated IIi). We previously showed that the HSV-1 immediate-early protein ICP22 is involved in this phenomenon, since induction of IIi and depletion of IIa are deficient in cells infected with 22/n199, an HSV-1 ICP22 nonsense mutant (S. A. Rice, M. C. Long, V. Lam, P. A. Schaffer, and C. A. Spencer, J. Virol. 69:5550-5559, 1995). However, depletion of IIo still occurs in 22/n199-infected cells. This suggests either that another viral gene product affects the RNAP II large subunit or that the truncated ICP22 polypeptide encoded by 22/n199 retains residual activity which leads to IIo depletion. To distinguish between these possibilities, we engineered an HSV-1 ICP22 null mutant, d22-lacZ, and compared it to 22/n199. The two mutants are indistinguishable in their effects on the RNAP II large subunit, suggesting that an additional viral gene product is involved in altering RNAP II. Two candidates are UL13, a protein kinase which has been implicated in ICP22 phosphorylation, and the virion host shutoff (Vhs) factor, the expression of which is positively regulated by ICP22 and UL13. To test whether UL13 is involved, a UL13-deficient viral mutant, d13-lacZ, was engineered. This mutant was defective in IIi induction and IIa depletion, displaying a phenotype very similar to that of d22-lacZ. In contrast, a Vhs mutant had effects that were indistinguishable from wild-type HSV-1. Therefore, UL13 but not the Vhs function plays a role in modifying the RNAP II large subunit. To study the potential role of UL13 in viral transcription, we carried out nuclear run-on transcription analyses in infected human embryonic lung cells. Infections with either UL13 or ICP22 mutants led to significantly reduced amounts of viral genome transcription at late times after infection. Together, our results suggest that ICP22 and UL13 are involved in a common pathway that alters RNAP II phosphorylation and that in some cell lines this change promotes viral late transcription.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10364308      PMCID: PMC112617     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  72 in total

Review 1.  Reversible phosphorylation of the C-terminal domain of RNA polymerase II.

Authors:  M E Dahmus
Journal:  J Biol Chem       Date:  1996-08-09       Impact factor: 5.157

2.  Distinct activated and non-activated RNA polymerase II complexes in yeast.

Authors:  A Akhtar; G Faye; D L Bentley
Journal:  EMBO J       Date:  1996-09-02       Impact factor: 11.598

3.  Trans-activation by human immunodeficiency virus Tat protein requires the C-terminal domain of RNA polymerase II.

Authors:  H Okamoto; C T Sheline; J L Corden; K A Jones; B M Peterlin
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

4.  In vitro characterization of a herpes simplex virus type 1 ICP22 deletion mutant.

Authors:  K L Poffenberger; P E Raichlen; R C Herman
Journal:  Virus Genes       Date:  1993-06       Impact factor: 2.332

5.  Processing of the herpes simplex virus regulatory protein alpha 22 mediated by the UL13 protein kinase determines the accumulation of a subset of alpha and gamma mRNAs and proteins in infected cells.

Authors:  F C Purves; W O Ogle; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

Review 6.  Transcription of the herpes simplex virus genome during productive and latent infection.

Authors:  E K Wagner; J F Guzowski; J Singh
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1995

7.  The human immunodeficiency virus Tat proteins specifically associate with TAK in vivo and require the carboxyl-terminal domain of RNA polymerase II for function.

Authors:  X Yang; C H Herrmann; A P Rice
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

8.  Interaction of the viral activator protein ICP4 with TFIID through TAF250.

Authors:  M J Carrozza; N A DeLuca
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

9.  The promoter and transcriptional unit of a novel herpes simplex virus 1 alpha gene are contained in, and encode a protein in frame with, the open reading frame of the alpha 22 gene.

Authors:  K L Carter; B Roizman
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

10.  Herpes simplex virus immediate-early protein ICP22 is required for viral modification of host RNA polymerase II and establishment of the normal viral transcription program.

Authors:  S A Rice; M C Long; V Lam; P A Schaffer; C A Spencer
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

View more
  70 in total

1.  Herpes simplex virus triggers and then disarms a host antiviral response.

Authors:  K L Mossman; P F Macgregor; J J Rozmus; A B Goryachev; A M Edwards; J R Smiley
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

2.  Distinct and separate roles for herpesvirus-conserved UL97 kinase in cytomegalovirus DNA synthesis and encapsidation.

Authors:  D G Wolf; C T Courcelle; M N Prichard; E S Mocarski
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

3.  RNA polymerase II holoenzyme modifications accompany transcription reprogramming in herpes simplex virus type 1-infected cells.

Authors:  H L Jenkins; C A Spencer
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

4.  Sequence variation in the herpes simplex virus U(S)1 ocular virulence determinant.

Authors:  Aaron W Kolb; Timothy R Schmidt; David W Dyer; Curtis R Brandt
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-06-28       Impact factor: 4.799

5.  The herpes simplex virus ICP0 RING finger domain inhibits IRF3- and IRF7-mediated activation of interferon-stimulated genes.

Authors:  Rongtuan Lin; Ryan S Noyce; Susan E Collins; Roger D Everett; Karen L Mossman
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

Review 6.  Herpes simplex virus virion host shutoff protein: immune evasion mediated by a viral RNase?

Authors:  James R Smiley
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

Review 7.  Peculiarities of herpes simplex virus (HSV) transcription: an overview.

Authors:  Július Rajcáni; Vojvodová Andrea; Rezuchová Ingeborg
Journal:  Virus Genes       Date:  2004-04       Impact factor: 2.332

8.  A truncation mutation of the neurovirulence ICP22 protein produced by a recombinant HSV-1 generated by bacterial artificial chromosome technology targets infected cell nuclei.

Authors:  Robert N Bowles; John A Blaho
Journal:  J Neurovirol       Date:  2011-12-03       Impact factor: 2.643

Review 9.  Breach of the nuclear lamina during assembly of herpes simplex viruses.

Authors:  Lynda A Morrison; Gregory S DeLassus
Journal:  Nucleus       Date:  2011-07-01       Impact factor: 4.197

10.  Efficient herpes simplex virus 1 replication requires cellular ATR pathway proteins.

Authors:  Kareem N Mohni; Alexander R Dee; Samantha Smith; April J Schumacher; Sandra K Weller
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.